Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
Sep. 30, 2024
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 19 - SUBSEQUENT EVENTS Subsequent to September 30, 2024, the Company issued an aggregate of 94,583 shares of its common stock for the Company’s President stock compensation and consulting services valued at $28,375. On October 7, 2024, the Company entered into a promissory note amendment agreement. In accordance with the agreement, the debt holder agreed to modify the amortization of payment terms and in exchange for the modification the Company issued an aggregate of 37,500 shares of common stock to the debt holder valued at $11,250. On October 14, 2024, the Company entered into three stock grant award agreements with the Company’s Controller and issued an aggregate of 150,000 shares of its common stock valued at $49,500. On October 14, 2024, the Company entered into two promissory note amendment agreements. In accordance with the agreements, the debt holder agreed to modify the amortization and the payment terms and in exchange for the modification the Company issued an aggregate of 150,000 shares of common stock to the debt holder valued at $49,500. On October 14, 2024, the Company entered into an Exchange Agreement with its President and Member of the Board of Directors, Mr. Louis Lucido. Pursuant to the agreement, Mr. Lucido agreed to exchange the aggregate of $387,600 of director's fees and loans to the Company’s subsidiary for 1,105,218 shares of common stock.

SUBSEQUENT EVENTS

9 Months Ended

Sep. 30, 2024

NOTE 19 - SUBSEQUENT EVENTS

Subsequent to September 30, 2024, the Company issued an aggregate of 94,583 shares of its common stock for the Company’s President stock compensation and consulting services valued at $28,375.

On October 7, 2024, the Company entered into a promissory note amendment agreement. In accordance with the agreement, the debt holder agreed to modify the amortization of payment terms and in exchange for the modification the Company issued an aggregate of 37,500 shares of common stock to the debt holder valued at $11,250.

On October 14, 2024, the Company entered into three stock grant award agreements with the Company’s Controller and issued an aggregate of 150,000 shares of its common stock valued at $49,500.

On October 14, 2024, the Company entered into two promissory note amendment agreements. In accordance with the agreements, the debt holder agreed to modify the amortization and the payment terms and in exchange for the modification the Company issued an aggregate of 150,000 shares of common stock to the debt holder valued at $49,500.

On October 14, 2024, the Company entered into an Exchange Agreement with its President and Member of the Board of Directors, Mr. Louis Lucido. Pursuant to the agreement, Mr. Lucido agreed to exchange the aggregate of $387,600 of director's fees and loans to the Company’s subsidiary for 1,105,218 shares of common stock.